Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001783403 | SCV002024921 | likely pathogenic | Congenital stationary night blindness 1B | 2023-09-11 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV001783403 | SCV002579845 | likely pathogenic | Congenital stationary night blindness 1B | 2021-12-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541150 | SCV003439302 | pathogenic | not provided | 2022-07-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro689Leufs*24) in the GRM6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRM6 are known to be pathogenic (PMID: 15781871, 16622103, 22008250). This variant is present in population databases (rs755967391, gnomAD 0.06%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1323039). This variant is also known as c.2062delC. This premature translational stop signal has been observed in individual(s) with congenital stationary night blindness (PMID: 22008250). |